By Andrew W. Griffin
Posted: August 4, 2009
OKLAHOMA CITY — With Oklahoma City under the microscope in coming weeks, in light of plans to test the new swine flu vaccine on hundreds of Oklahoma children, many questions remain unanswered and Red Dirt Report will look to provide more information.
First of all, the company conducting this research, IPS Research Company, located in downtown Oklahoma City, is, according to the website, “a leading clinical research facility” that conducts all sorts of medical trials addressing problems related to anxiety disorders, bipolar disorder, major depression and Alzheimer’s disease, among many others.
IPS told The Oklahoman last week that they are hoping to attract young volunteers to be used as test subjects – guinea pigs, in the common parlance – to see how effective the new swine flu vaccine will be on their young, developing “patients,” starting on August 17.
And the medical director for IPS Research, Dr. Louise Thurman, told The Oklahoman that “(f)rom a science standpoint, it should work.”
I’m sorry Dr. Thurman, that’s not good enough. Are our children’s lives and well-being worth the risk, particularly in light of swine flu levels plateauing around the world, according to news reports this week.
And here at Red Dirt Report, we reported as well that there were some serious problems with this plan, particularly that they were fast-tracking the release of the vaccine.
Today, PrisonPlanet.com reporter Paul Joseph Watson revealed that the University of Alabama in Tuscaloosa was planning to require all students to get their meningitis and MMR shots before enrolling and that those that did not do this, including juniors and seniors who may have avoided doing so, will face either disciplinary action or will not be able to enroll.
Having attended the University of Alabama in the late 1990’s, and having siblings who received their graduate degrees there, your Red Dirt Reporter had a particular interest in this story and subject.
After alerting the Crimson White, the university’s student newspaper, which this reporter contributed to in 1998, a reporter there said she was unaware of the new policy and would alert the editor. Later, Red Dirt Report contacted the university public relations office and eventually spoke with Chris Bryant, a university spokesman.
Bryant listened to our questions and concerns about this development and said he would speak to others and that Red Dirt Report would have those questions answered, presumably with a return call from a university official “higher up the totem pole,” as it were.
Well, Thursday afternoon, Bryant sent the following email:
I’m told that we’ve distributed similar notices for the last few years. Last year, our major emphasis was on incoming freshman who lived on campus. This year we’re expanding requirements for the meningitis vaccination to juniors and seniors living on campus. We’re following guidelines suggested by the American College Health Association. Our approach is similar to most universities. We’re continuing to try and keep campus a safe place to learn, work and have fun.
So, it appears that the American College Health Association (ACHA) is behind this push for vaccinations of all students. Research into this revealed an article posted at the University of Minnesota’s Center for Infectious Disease Research and Policy headlined “ACIP targets up to 159 million Americans for H1N1 vaccination.”
ACIP is the Advisory Committee on Immunization Practices.
The ACHA wants young people, up to the age of 24, rather than 18 – in order to include college students- for vaccine prioritization. This, they say, due to college students being in dormitory settings that could lead to the rapid spread of H1N1. It noted that several summer camps closed because of the spread of the disease in camp conditions.
Upping the age would add 24 million people to the priority group, therefore requiring much more vaccine to be created and distributed at a considerable profit for the swine flu vaccine manufacturers.
In the article, quoting Dr. Anne Schuchat of the Centers for Disease Control and Prevention, the ACIP has “picked five targe groups for initial immunization because of their increased risk of H1N1 (swine flu) infection or compicationsor their contact with vulnerable people:
1. Pregnant women; 2. Healthcare and EMS workers who have direct contact with patients or infectious substances; 3. Household contacts of babies yonger than 6 months; 4. Children aged 6 months through 4 years; 5. Children and adolescents from 5 through 18 years who have risk factors for flu complications.
Everyone else, notes the article, “can be immunized after the demad from the target groups has been met.” So, expect a lot of propaganda geared towards young mothers and children, some of our most vulnerable citizens.
Much has been said about “adjuvants,” which are oil-based additives that can cause adverse auto-immune responses. Squalene is one such example and has been linked to Gulf War Syndrome, something this reporter investigated 10 years ago, interviewing Gulf War soldiers in Louisiana who were subjected to dangerous vaccines and never recovered.
The ACIP report notes that “the H1N1 vaccines to be use will not contain adjuvants, because using an adjuvant would create regulatory complications that would delay vaccine availability.”
As noted in Gary Matsumoto’s excellent 2004 book Vaccine A, scientists discovered in laboratory animal tests that squalene caused all sorts of painful problems for the lab animals. However, reports showing adjuvants and squalene causing all sorts of problems in vaccines, were “ignored” by the National Institutes of Health, which took a “see-no-evil” stance.
Matsumoto writes of Patient X, a test subject who was injected with a placebo containing squalene – a substance used in many vaccines – and had horrific side effects, despite the placebo being something that should remain inert.
The adjuvant, addressed by Patient X’s attorney says: The adjuvant “is itself an experimental drug whose side effects are not yet fully known, and for which there had not yet been done adeuate human testing to know at what levels different toxicities are to be expected.” The adjuvant, Matsumoto writes, is something called MG59, which is squalene and water.
But back to the CIDRAP/ ACIP report …
Of note, the reporters in this article, Robert Roos and Lisa Schnirring, inject some skepticism – unwittingly, we assume – because the government health officials make numerous vague statements, never giving hard core specifics, leading the reporters to end sentences “without offering details.”
The article also notes that concerns about mercury-laden thimerosal, used in vaccines as a preservative, would still be used in the swine flu vaccines but that the Department of Health and Human Services “has ordered some thimerosal-free vaccine, both injectable and the nasal spray, but did not specify quantities.”
Thimerosal is often connected to leading to autism in children.
In the meantime, the mainstream media continues to beat the drum over the swine flu vaccine and how the pandemic will be terrible by the autumn and that preparations must be made now.
But then, why are any of us surprised by this disturbing development? Earlier this week, Dr. Marc Siegel, a contributor to Fox News Channel was on with morning show hosts Bill Hemmer and Megyn Kelly pushing hard for people to get the swine flu vaccine. In fact, news reports are calling for pregnant women to get the swine flu vaccine.
Will there be forced vaccinations? The University of Alabama isn’t outright saying that but students are strongly urged to take the shot, as they are at other universities, if the ACHA report is to be taken seriously.
Red Dirt Report looks forward to speaking with the folks at IPS Research this coming week and hopefully have questions answered related to the swine flu vaccine trials involving children who should be protected rather than subjected to unproven vaccines containing all sorts of dangerous ingredients.